PKM and hepatocellular carcinoma: To test this hypothesis, we used shikonin, a potent PKM2 inhibitor derived from the traditional Chinese medicine Arnebiae Radix with anti-inflammatory and anticarcinogenic activities, in combination with sorafenib to treat HCC.